In mammals, hypothalamic control of food intake involves counterregulation of appetite by anorexigenic peptides such as corticotropin-releasing factor (CRF), and orexigenic peptides such as neuropeptide Y (NPY). Glucocorticoids also stimulate food intake by inhibiting CRF while facilitating NPY actions. To gain a better understanding of the diversity and evolution of neuroendocrine feeding controls in vertebrates, we analysed the effects of CRF, NPY and glucocorticoids on food intake in juvenile Xenopus laevis. We also analysed brain CRF and NPY mRNA content and plasma corticosterone concentrations in relation to nutritional state. Intracerebroventricular (i.c.v.) injection of ovine CRF suppressed food intake while CRF receptor antagonist ahelical CRF(9±41) signi®cantly increased food intake relative to uninjected and placebo controls. By contrast, i.c.v. injection of frog NPY and short-term corticosterone treatment increased food intake. Semi-quantitative reverse transcription-polymerase chain reaction analyses showed that CRF and NPY mRNA¯uctuated with food intake in the brain region containing the mid-posterior hypothalamus, pretectum, and optic tectum: CRF mRNA decreased 6 h after a meal and remained low through 31 days of food deprivation; NPY mRNA content also decreased 6 h after a meal, but increased to prefeeding levels by 24 h. Plasma corticosterone concentration increased 6 h after a meal, returned to prefeeding levels by 24 h, and did not change with prolonged food deprivation. This postprandial increase in plasma corticosterone may be related to the subsequent increase in plasma glucose and body water content that occurs 24 h postfeeding. Overall, our data support the conclusion that, similar to other vertebrates, CRF is anorexigenic while NPY is orexigenic in X. laevis, and CRF secretion modulates food intake in the absence of stress by exerting an inhibitory tone on appetite. Furthermore, the stress axis is activated in response to food intake, but in contrast to mammals and birds is not activated during periods of food deprivation.
CRF secretion may exert a suppressive action on orexigenic neurones (e.g. NPY) because CRF is known to inhibit NPY synthesis (7) . Circulating glucocorticoids stimulate food intake via two pathways. First, glucocorticoids are a permissive factor that facilitates the orexigenic effect of NPY because adrenalectomized rodents do not increase food intake when exogenous NPY treatments are applied (9) . Second, glucocorticoids inhibit CRF neurones, thus reducing the anorexigenic effects of CRF (1) .
The central distributions of CRF and NPY neurones have been mapped in the amphibian brain (10, 11) , but little is known about their physiological actions in amphibians. The roles of CRF and corticosterone in development have been analysed in several amphibian species (12) , although few studies have investigated the involvement of these hormones in the regulation of food intake. Central injections of CRF inhibit food intake and preycatching behaviour in two frog species (2, 13) . Long-term treatment with corticosterone suppressed growth in Rana pipiens tadpoles (14) ; however, it is not known if the growth inhibition was caused by a reduction in food intake, an inhibition of growth independent of feeding, or a combination of both. The actions of NPY have been studied in the South African clawed frog, Xenopus laevis, in the context of background adaptation (15) , but not in the context of food intake regulation. In these studies, NPY inhibited secretion of a-melanocyte-stimulating hormone, an anorexigenic neuropeptide that also promotes skin darkening (15) .
The present study focused on the roles of CRF, NPY and corticosterone in the regulation of food intake in the X. laevis. We experimentally addressed the following questions: (i) does exposure to exogenous CRF, NPY, or corticosterone affect food intake and (ii) does brain CRF or NPY mRNA content, or plasma corticosterone concentration vary with nutritional state? If CRF acts as an appetite suppressant in frogs, we predicted that exogenous CRF would suppress food intake, and that hypothalamic CRF mRNA expression would be negatively correlated with appetite. If NPY and corticosterone stimulate appetite in X. laevis, as they do in other vertebrates, then exogenous NPY and corticosterone should increase food intake. Furthermore, we predicted that brain NPY mRNA content and plasma corticosterone concentration would be positively correlated with appetite. We also measured plasma glucose, plasma insulin-like growth factor binding proteins (IGFBPs), and physical parameters (e.g. body and fat mass) as indicators of energy balance.
Materials and methods

Animal husbandry
All procedures were conducted in accordance with the guidelines established by the University Committee on Use and Care of Animals at the University of Michigan. Xenopus laevis juveniles were obtained from an in-house breeding stock originally derived from the population at Xenopus I (Dexter, MI, USA). For all experiments, frogs were maintained at 23 8C on a 12 : 12 h light dark cycle (lights on at 07.00 h and off at 19.00 h) in 4-l aquaria (29 Â 19 Â 12.5 cm).
Hormones and reagents
Ovine CRF (oCRF, Sigma-Aldrich, St Louis, MO, USA) and ahelical-CRF(9-41) (Sigma) were used in experiments examining CRF effects on food intake in X. laevis. We chose to use ovine CRF rather than X. laevis CRF as the former binds to X. laevis CRF receptors with an af®nity similar to the X. laevis CRF (16) but does not bind to the X. laevis CRF-BP (16) . Thus, the use of oCRF should remove any confounding effects of binding to endogenous CRF-BP, which is expressed at a high concentration in the X. laevis brain (17) . Corticosterone was obtained from ICN Biomedicals (Aurora, OH, USA). Frog NPY was synthesized by solid phase methodology as previously described (18) ; the amino acid sequence of this peptide is identical to that of X. laevis NPY.
Food intake assay
Frogs were given introcerebroventricular (i.c.v.) injections of neuropeptides (described below) and, 1 h later, they were given a measured quantity of beef liver pieces (approximately 10 mg/piece). After 10 min, the food remaining was retrieved from the tank, blotted of excess water and weighed. Food intake was measured as the remaining mass of food (mg) subtracted from the original food mass, divided by the body weight of the frog in grams (g b.w.). Analysis of variance (ANOVA) was used to determine if food intake varied among treatment groups, and Duncan's multiple comparisons tests were used to determine within-treatment differences in food intake.
Plasma corticosterone radioimmunoassay (RIA)
Corticosterone was analysed in plasma by RIA following ether extraction (100 ml plasma per sample). To estimate recoveries, [ 3 H]-corticosterone (3500 c.p.m.) was added to each plasma sample and incubated at room temperature for 30 min before extraction. Samples were resuspended in 500 ml assay buffer (PBS-G: 0.02 M sodium phosphate, pH 7.3, 0.9% NaCl, 0.1% gelatin) and analysed by RIA as described by Licht et al. (19) . Anti-corticosterone serum was purchased from Endocrine Sciences (Calabasas, CA, USA), and [ All samples within an experiment were analysed within a single RIA, except for those in the Satiation/Food Deprivation Experiment (samples from each time collection were represented in each of the ®ve assays). Two samples of pooled extracted normal rabbit serum were included in each assay as quality control standards. The interassay coef®cient of variation was 16%. Plasma samples exhibited parallelism in the RIA. ANOVA was used to measure time differences in plasma corticosterone concentrations.
Effects of CRF on food intake
Experiment 1
The purpose of this experiment was to determine if CRF exerts a dose-dependent inhibitory effect on food intake. All juvenile X. laevis (0.6±1.5 g b.w.) were fed once every other day at 12.00 h for at least 10 days. Frogs were fasted for 48 h before injections to ensure that appetite would be high before the experiment. On the day of the experiment, frogs were anaesthetized by submersion in 0.005% benzocaine. We administered i.c.v. microinjections of saline (vehicle control) or oCRF (n 5±6) at the following doses (n b.w.): 0.02, 0.20 and 2.0. A volume of 100±150 nl containing the appropriate dose of oCRF was pressure injected with a micropipette. Based on the microinjection procedure of Lowry and Moore (20) , we ®rst pierced a hole through the skull using a 26.5-gauge needle, then inserted the micropipette through the hole into the third ventricle using a Drummond Nanoject apparatus (Drummond Scienti®c Co, Bromwell, PA, USA). The precise position of the needle for delivery was determined in preliminary experiments by injection of 1% fast green dye; however, no dye was used in the CRF injection experiments. After injection, frogs were placed in tanks without anaesthetic for recovery. The frogs typically recovered within 20 min after injection, and food intake was assayed as described above.
Experiment 2
To test if the action of CRF was speci®cally mediated through CRF receptors and whether endogenous CRF secretion regulates food intake, we conducted an experiment using the CRF receptor antagonist, ahelical CRF(9±41), which binds to both CRF receptor types. We fed juveniles (1.0±2.0 g b.w.) approximately 20 mg of beef liver each at 4 h before injection to ensure that appetite would be relatively low among experimental frogs, and conducted the same anaesthesia and i.c.v. injection procedures described in experiment 1. The frogs (n 7) were given i.c. . We also included a noninjected (`unstressed') group in this experiment. Food intake was assayed as described above.
Effects of NPY on food intake
To determine the effect of NPY on food intake, we fed juveniles (0.6±1. injection procedures were the same as described above. Frogs (n 8) were given i.c.v. injections of saline (vehicle control), 10 ng/g b.w. frog NPY or 100 ng/g b.w. frog NPY. Food intake was assayed as described above.
Effects of corticosterone on food intake
To determine the effect of corticosterone on food intake, we treated frogs noninvasively with either corticosterone or a corticosterone synthesis blocker (metyrapone). On the ®rst day of the experiment, frogs (n 5 per treatment) were fed liver pieces to satiation at 12.00 h. After feeding, the frogs were placed in 2 l of water to which ethanol vehicle (0.0043% ®nal concentration; control), corticosterone (2 mM ®nal concentration) or metyrapone (0.11 mM ®nal concentration) were added. Metyrapone is a corticosterone synthesis inhibitor that has been used successfully in frogs (14, 21) . In previous experiments, this concentration of metyrapone did not cause any obvious pathological behaviours in X. laevis juveniles or tadpoles. After 24 h, frogs were submerged in 0.01% benzocaine, killed, and plasma was collected with heparinized capillary tubes from an incision in the truncus arteriosus for corticosterone RIA. In a separate experiment, we tested the effects of corticosterone or metyrapone on food intake by exposing juvenile frogs (n 4 per treatment) to hormone or drug treatments for 24 h, then assaying food intake as described above.
Satiation/food deprivation experiment
The purpose of this experiment was to determine if brain CRF or NPY mRNA content or plasma corticosterone concentration vary with level of appetite and nutritional state. Juveniles (4.8±9.5 g b.w.) were housed individually in 4-l containers and hand-fed approximately 100 mg of liver pieces each at 12.00 h every other day for 10 days. After a 48 h fast, frogs were allowed to feed ad libitum until satiated. The frogs were randomly assigned to one of 11 collection groups (n 6±7 per group) such that there were no signi®cant differences in mean body size among groups. To measure immediate responses to food intake, blood samples and brain sections were collected in a prefeeding sample (À1 h) and three postfeeding samples (2, 6 and 24 h). To measure changes in response to short-term food deprivation, blood samples and brain sections were collected at 12.00 h on 2±6 days after the satiation meal. Finally, to measure changes in response to long-term food deprivation, blood samples and brain sections were collected at 12.00 h on days 14 and 31 after the satiation meal.
At each collection time, frogs were anaesthetized by submersion in 0.005% benzocaine and blood samples were collected into heparinized capillary tubes from an incision in the truncus arteriosus. Two brain sections were analysed for mRNA content. Section 1 included the olfactory lobes, telencephalon, anterior hypothalamus (preoptic area) and Section 2 included the mid-posterior hypothalamus, pretectum, optic tectum, and pituitary. Tissues were snap frozen on dry ice after dissection and stored at À80 8C until processed. Plasma was stored at À20 8C until assayed for corticosterone.
In addition, wet body mass, stomach content mass, and abdominal lipid body mass were measured. Wet body mass was calculated by subtracting the masses of the stomach contents and abdominal fat bodies from the total wet mass of the frog. Frog carcasses (not including fat and stomach contents) were then dried in an oven at 55 8C and weighed for lean body mass. Multivariate analysis of variance (MANOVA) was used to analyse physical body measurements, using time of sample as a main effect and original mass as a covariate.
CRF and NPY mRNA measurement
To assess changes in CRF and NPY mRNA content in the two brain regions, we used semiquantitative multiplex reverse transcription-polymerase chain reaction (RT-PCR) analysis. Total RNA was extracted from brain tissues with TRIzol (Life Technologies, Carlsbad, CA, USA) following the manufacturer's protocol, and RNA concentrations were quanti®ed by spectrophotometry. Total RNA was reverse transcribed into cDNA according to the Clontech Laboratories, Inc. (Palo Alto, CA, USA) protocol for ®rst strand cDNA synthesis using a poly dT primer. Each RT reaction included: 1 mg total RNA, 5 Â ®rst strand buffer, 0.1 M DTT, 10 mM dNTPs and 1 ml of Superscript II RNase H ± reverse transcriptase (Invitrogen Inc., Groningen, the Netherlands). After 1.5 h of cDNA synthesis at 42 8C, reactions were terminated by incubation at 71 8C for 10 min then stored at 4 8C.
We analysed the potential for genomic DNA contamination of our RNA samples by conducting PCR on one-third of the RT products using primers designed to amplify a region of genomic DNA (1 kb) upstream of the transcription start site of the X. laevis CRFa gene (22) . As positive controls for the PCR, we used puri®ed X. laevis genomic DNA or a plasmid containing the X. laevis CRFa gene (22) . This analysis con®rmed that genomic DNA was not present in any of our samples and thus the DNA fragments that we analysed were derived from cDNA.
For semiquantitative multiplex PCR, we used the X. laevis ribosomal protein L8 (rpL8) to control for differences in RNA loading, RNA quality and cDNA synthesis (23) . We conducted two 25 ml PCR reactions for each sample: one with primers for CRF and rpL8, and another with primers for NPY and rpL8. H -CAGGATGG-GTTTGTCAATACG. The size of the PCR products for CRF, NPY and rpL8 were 321 bp, 240 bp and 477 bp, respectively. Before multiplex PCR analysis, a thermal gradient of annealing temperatures and a series of cycle numbers were tested for each brain section and primer set to determine optimal PCR conditions. Following procedures described by Pernas-Alonso et al. (24) , primer concentrations were adjusted so that the linear ranges of ampli®cation for each gene were coincident so that measurement of each gene could be made from a single reaction. The speci®cs for each primer set and brain section are reported below.
For CRF analysis, each reaction contained 1 ml RT product, 0.3 mM of each CRF primer, 0.08 mM of each rpL8 primer, 1.5 mM MgCl 2 and 1.25 U HotStar Taq DNA polymerase (Qiagen Ltd, Crawley, UK). The PCR conditions were 15 min at 95 8C, followed by 30 cycles (brain Section 1) or 28 cycles (brain Section 2) of 94 8C for 45 s, 61 8C for 45 s, and 72 8C for 1 min, and a ®nal 10-min extension at 72 8C. For NPY analysis, each reaction contained 1 ml RT product, 0.2 mM of each NPY primer, 0.1 mM of each rpL8 primer, 1.5 mM MgCl 2 and 1.25 U Taq DNA polymerase (Buffer B, Promega Inc., Madison, WI, USA). The PCR conditions for analysis of both brain regions were 4 min at 94 8C, followed by 29 cycles of 94 8C for 1 min, 60 8C for 1 min and 72 8C for 2 min, and a ®nal 10 min of elongation at 72 8C.
PCR products were analysed on a 1.5% agarose gel. Ethidium bromide-stained bands were visualized by ultraviolet illumination and images were digitally recorded. The intensity of each band was quanti®ed by densitometric analysis using Scion Image software (version 4.05 for Windows) (Scion Corp. Frederick, MD, USA). For each gene, densitometric values were ®rst standardized by dividing by the group mean. CRF and NPY values were then normalized for differences in RNA loading by dividing by the corresponding rpL8 densitometric values. These ratios were square-root transformed and analysed with ANOVA. Data for both CRF brain sections were taken from two separate gels with samples from each treatment equally distributed among the gels; therefore, we conducted a two-factor ANOVA to account for gel and treatment differences in band intensity (i.e. neuropeptide content). The NPY data for each brain section were collected from a single gel. Accordingly, only the treatment effect was analysed in the ANOVA.
Plasma glucose assay
Plasma glucose was assayed using Sigma Diagnostics procedure no. 510, which was modi®ed from Raabo and Tirkildsen (25) . Five ml of plasma per frog was added to 95 ml distilled deiodinized (dd) water and 1 ml of glucose oxidase, peroxidase and odianisidine mixture. All samples were incubated at 37 8C for 30 min. Within 3 min after incubation, 250 ml of each sample was analysed in a plate spectrophotometer (Titertek Multiscan Plus, ICN Biomedicals Inc., Huntsville, AL, USA) for light absorbency using a 450 nm ®lter. Serum glucose (mg/dl) was calculated by dividing the sample optical density reading by the standard reading, then multiplying by 100. Analysis of variance was used to analyse plasma glucose concentration with time of sample as a main effect. Because glucose was measured in two runs, with replicates of each treatment in each run, we included run and treatment as main effects in the ANOVA.
IGFBP Western ligand blot analysis
We measured plasma concentrations of IGFBPs as an endocrine indicator of nutritional state. Currently, there are no homologous assays established for other indicators, such as insulin, glucagon, or IGF-1 in amphibians, but Western ligand blot analysis enabled us to analyse relative levels of plasma IGFBPs. Given that IGFBP-1 concentration is positively regulated by insulin and negatively regulated by glucagon in mammals (26, 27) , and previous studies in mammals and ®sh have shown that elevations in plasma IGFBP-1 levels are associated with food deprivation (28, 29) , we hypothesized that the X. laevis plasma IGFBP pro®le would reveal a similar pattern. We followed the methods of Hossenlopp et al. (30) with modi®cations. Plasma samples (5 ml) were dissolved in SDS sample buffer (Tris base, 0.125 mol/l; 4% SDS; 20% glycerol, 0.1% bromophenol blue) and heated to 65 8C for 10 min before electrophoresis in a 10% polyacrylamide gel. A pool of rat plasma (5 ml) was run on each gel to serve as a quality control standard because the rat blood IGFBP banding pattern is known.
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Proteins were transferred to nitrocellulose membranes (Bio-Rad, Hercules, CA, USA) and the membranes were blocked overnight in tris-buffered saline containing 1% bovine serum albumin (TBS-BSA). Blots were then rinsed and probed with [ 125 I]-labelled human IGF-I (iodinated by the chloramine T method) at 200 000 c.p.m./ml TBS-BSA. Following autoradiography, images were digitized using a¯atbed scanner and the resulting IGFBP bands were quanti®ed using Scion Image software as described above. We considered band intensity, calculated in arbitrary densitometric units, to be a relative measure of plasma IGFBP levels. Analysis of variance was used to analyse band intensity from the ligand blots; because ®ve blots were used to analyse all the samples, blot and time of collection were included as main effects in the ANOVA.
Measurement of daily¯uctuations in plasma corticosterone and glucose concentration
To determine if plasma corticosterone and glucose concentrations¯uctuated during the day without a meal, we measured plasma concentrations twice a day for 3 days. Frogs (4.0±8.0 g b.w.) were housed individually in 4-l aquaria and entrained to a feeding cycle in which they were fed at 13.00 h every 48 h for 2 weeks. In continuance with the feeding regime, one meal was given at 13.00 h on the ®rst day of collections, but frogs were fasted on subsequent days. Plasma samples (n 4±5) were collected at the following times: day 1: 12.00 h (prefeeding) and 18.00 h (5 h postfeeding); day 2: 12.00 h and 18.00 h; day 3 12.00 h and 18.00 h. Plasma corticosterone was measured by RIA, and plasma glucose was measured by enzymatic assay (see above).
Results
CRF effects on food intake
Injections of oCRF into the third ventricle reduced food intake in a dose-dependent manner relative to vehicle-injected controls [ANOVA: F(3,18) 3.89, P 0.026] (Fig. 1A) . Blockade of CRF receptors by injection of ahelical CRF(9±41) signi®cantly increased food intake compared with uninjected and salineinjected groups [ANOVA: F(4,30) 5.86, P < 0.001] (Fig. 1B) . Food intake in frogs coinjected with CRF plus ahelical CRF(9±41) did not differ from either control group [i.e. ahelical CRF(9±41) blocked the anorectic effect of CRF].
NPY effects on food intake
Injections of either 20 ng/g or 200 ng/g frog NPY signi®cantly increased food intake in X. laevis juveniles relative to controls [ANOVA: F(2,21) 3.47, P 0.008] (Fig. 1C) .
Corticosterone effects on food intake
Treatment with corticosterone (2 mM) for 24 h caused an approximate three-fold increase in plasma corticosterone concentration above controls (Fig. 2A) . This treatment also increased food intake relative to vehicle-treated controls (Fig. 2B) . By contrast, metyrapone reduced plasma corticosterone concentration to nondetectable levels [ANOVA: F(2,11) 8.74; P 0.005], but did not alter food intake [ANOVA: F(2,9) 17.34; P 0.0008].
Satiation/food deprivation experiment
Physical measurements
Stomach contents increased by approximately 17% of total body mass after the meal but, by 6 h, approximately half the food had cleared the stomach (Table 1) . Almost all food cleared the stomach by 2 days after the meal. Neither wet nor dry body mass signi®cantly changed with collection time, but body water content signi®cantly increased 1 day after feeding relative to the prefeeding sample (Table 1 ). The wet mass of fat bodies was signi®cantly lower than prefeeding fat mass on days 5 and 31 of food deprivation (Table 1) .
CRF and NPY content analysis
Semi-quantitative RT-PCR analyses revealed that both CRF and NPY mRNA expression varied with nutritional state in the forebrain/anterior hypothalamic region (Section 1) and the midbrain/ mid-posterior hypothalamic region (Section 2) (Fig. 3A) . Analysis of variance also con®rmed that the mRNA levels of the housekeeping gene, rpL8, did not vary among treatments in any of the analyses (unpublished data). CRF mRNA expression in Section 1, which included the preoptic area, did not change following food deprivation (compared to the prefeeding level) except at day 4 [ANOVA: F(10,42) 2.16, P 0.039] ( Table 2 ). In brain Section 2, which included the mid-posterior hypothalamus, tectum, and pretectum, CRF mRNA expression declined immediately after feeding to a level signi®cantly lower than that of the prefeeding group by 6 h after the meal [ANOVA: F(10,42) 3.33, P 0.004] (Fig. 3B) . CRF mRNA expression in all subsequent food deprivation periods was signi®cantly lower than in the prefeeding group (Table 2) .
NPY mRNA expression in brain Section 1 signi®cantly decreased by 1 day after the meal ( Fig. 3B) , but returned to prefeeding levels by 2 days of food deprivation [ANOVA: F(10,40) 2.09, P 0.049]. However, after 31 days of food deprivation, NPY mRNA expression was signi®cantly lower than prefeeding levels (Table 2 ). In brain Section 2, NPY mRNA expression decreased by 6 h after feeding, but then returned to prefeeding levels after 1 day [ANOVA: F(10,39) 2.46, P 0.020) ( Table 2 , Fig. 3B ). Fluctuation of CRF and NPY mRNA concentrations with feeding and food deprivation in X. laevis juveniles (n 3±5). Ribosomal protein rpL8 was used as a housekeeping gene to control for loading differences, and values represent the ratio in band intensity of CRF or NPY to rpL8. Ã Sample mean is signi®cantly different (P < 0.05) from the prefeeding group (À1 h). Signi®-cance determined by Dunnett±Hsu multiple comparisons tests on least-squares means for CRF mRNA, and Duncan's multiple comparisons tests on ratio means for NPY mRNA. Fig. 2 . Effects of 24 h of exposure to aquarium water treated with corticosterone (2 mM, CORT) or corticosterone synthesis inhibitor metyrapone (0.11 mM) on (A) plasma corticosterone concentration and (B) food intake in Xenopus laevis juveniles. Controls were exposed to aquarium water treated only with vehicle (ethanol at 0.0043%).
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Plasma corticosterone measurements
There was a peak in plasma corticosterone concentration 6 h after the meal compared with the prefeeding level (Fig. 4A) ; however, the full model that analysed plasma corticosterone concentration over the 31-day period of food deprivation was not signi®cant at a 0.05 [ANOVA: F(9,39) 1.92; P 0.08]. To con®rm the trend of a corticosterone peak at 6 h, we conducted a separate experiment that replicated the prefeeding (À6 h), 6-h, 1-day, 2-day and 14-day food deprivation treatments (n 3). The frogs were entrained to feeding times in the same way as those in the ®rst experiment. This experiment con®rmed a signi®cant increase in plasma corticosterone concentration 6 h after the meal compared to the prefeeding group (also see results from Daily Fluctuations in Plasma Corticosterone Experiment), with no further increases following food deprivation of 1, 2, or 14 days [ANOVA: F(4,10) 7.61; P 0.006] (Fig. 4A, inset) .
Plasma glucose and IGFBPs
Plasma glucose concentration increased 1 day after feeding and returned to prefeeding levels by two days after feeding [ANOVA: F(10,54) 2.60; P 0.019] (Fig. 4B) . Plasma glucose concentration remained relatively constant at approximately 70 mg/dl through 31 days of food deprivation. We also measured plasma IGFBPs because plasma pro®les of IGFBP-1 are known to vary with energy balance in other vertebrates (26±29). Western ligand blot analysis resolved two IGFBP bands in X. laevis plasma (approximately 35 kDa and 25 kDa, respectively) (Fig. 5A) . We did not attempt to determine the identities of these proteins in X. laevis. The 25-kDa IGFBP band (hereafter referred to as xBP25) was similar in size to mammalian and ®sh IGFBP-1 (27, 28) , and increased with food deprivation as previously shown in other vertebrate groups (28, 29) . Plasma xBP25 levels increased within 2 h after satiation feeding, peaked at 2 days after feeding, and remained signi®cantly higher than the prefeeding levels through 6 days of food deprivation [ANOVA: F(10,54) 7.48; P < 0.0001] (Fig. 5B) . We detected no signi®cant difference in the plasma levels of the 35-kDa protein (xBP35) with nutritional state.
Measurement of daily¯uctuations in plasma corticosterone and glucose concentration
The purpose of this experiment was to determine whether daily plasma corticosterone¯uctuations occur in frogs that had not been fed. In frogs entrained to a 13.00 h feeding time, plasma corticosterone concentrations were consistently low (3.2±4.3 ng/ml) in samples taken at 12.00 h over the course of the 3 days, but were elevated (> 8 ng/ml) in the 18.00 h samples [ANOVA: F(5,20) 3.32; P 0.02] (Fig. 6A) . As in the previous experiment, the postfeeding (day 1, 18.00 h) plasma corticosterone concentration was signi®cantly greater than the prefeeding sample and all other 12.00 h samples. The 18.00 h samples taken on days without a meal were intermediate between the 12.00 h samples and the postfeeding sample. Plasma glucose concentration was signi®-cantly elevated in frogs sampled 24 h after the meal as in the previous experiment; all other samples were not signi®cantly different from the day 1 prefeeding sample [ANOVA: F(5,24) 3.86; P 0.01] (Fig. 6B) .
Discussion
The mammalian model of central nervous system control of energy balance proposes that food intake is regulated within the hypothalamus by alternating actions of anorexigenic and orexigenic neuropeptides (7) . In general, our data suggest that this model can also be applied to amphibians. In X. laevis, we found that i.c.v. injections of CRF suppressed food intake, whereas i.c.v. injections of NPY increased food intake as shown previously in mammals, birds, and ®shes (2). Here, we present the ®rst in vivo evidence for an orexigenic role for NPY in an amphibian, and our ®nding that CRF reduced meal size in X. laevis supports two previous studies in which CRF i.c.v. injections suppressed prey-catching behaviour in other species of frogs (2, 13). We also found that blocking CRF receptors increased food intake relative to uninjected controls (i.e.`no-stress'), suggesting that basal (i.e. unstressed) CRF secretion modulates food intake in X. laevis. Although many studies in mammals and ®shes have shown that treatment with ahelical CRF(9±41) blocks stress-induced suppression of food intake (1, 31) , this is the ®rst report of an increase in food intake resulting from the blockade of CRF receptors in the absence of stress. The effect of ahelical CRF(9±41) in X. laevis is similar to that of CRF-BP overexpression in mice, which also increases food intake, presumably by reducing the free CRF concentration (8) . Although the speci®c brain regions that mediate CRF effects on food intake is unknown in frogs, our data support the hypothesis that in the absence of stress, basal CRF secretion regulates food intake by eliciting a tonic, suppressive effect on appetite in amphibians.
The changes in hypothalamic CRF and NPY mRNA content with nutritional state in X. laevis also support the hypothesis that these neuropeptides have conserved appetite regulation functions across vertebrates. We found that NPY mRNA content was signi®cantly lower in the midbrain region (section 2) by 6 h after a meal when appetite was suppressed, but returned to prefeeding levels by 1 day after the meal when appetite increases. Although we did not detect a signi®cant increase with longer periods of food deprivation as seen in mammals (7), NPY mRNA levels remained signi®cantly higher than the 6 h postmeal measure in almost all food deprivation treatments. The increase in NPY mRNA content with food deprivation was also shown by Northern blot analysis of X. laevis midbrain sections sampled 6 h after a meal and after 14 days of food deprivation (E.J. Crespi and R.J. Denver, unpublished data). Given that we measured mRNA content in gross sections of the brain, it is possible that we did not detect increases in neuropeptide gene expression occurring within limited populations of cells in the tissue sample. Alternatively, NPY mRNA expression may not have increased beyond its 24 h postmeal levels because appetite does not increase with prolonged periods of food deprivation in X. laevis. For example, we found that frogs deprived of food for 31 days do not eat more in a single meal than frogs deprived of food for only 2 days (E.J. Crespi and R.J. Denver, unpublished data).
Although we did not observe an up-regulation of CRF mRNA during times of satiation (2 h and 6 h after feeding) as shown in mammals (32), we observed a signi®cant decrease in CRF mRNA content with food deprivation when appetite is high, as also shown in mammals (33±35). Surprisingly, we saw the reduction in CRF mRNA content in the brain section containing the preoptic/optic tectum/mid-posterior hypothalamus (Section 2), but not in the section containing the preoptic area [homolog to the mammalian paraventricular nucleus (PVN); Section 1]. Studies in mammals have shown that CRF content is reduced in the PVN with food deprivation (33±35); however, most studies focus only on the PVN, even though other areas of the brain may be involved, because it is where CRF expression and secretion increases in response to physical and psychological stressors (1, 36) . It is possible that we were unable to detect changes in CRF expression in the preoptic area because we measured mRNA in gross brain regions, and future studies using histochemistry would resolve this issue. Nevertheless, our results suggest that, in addition to the preoptic area, neurones in the mid-posterior hypothalamus, pretectum, and optic tectum may be important in CRF regulation of food intake and energy balance in X. laevis.
Although the effects of CRF and NPY on food intake appear to be similar between X. laevis and mammals, there were both similarities and differences in the plasma corticosterone pro®le with food intake and deprivation. First, as shown in mammalian studies (3, 4) , acute increases in corticosterone signi®cantly increased food intake in X. laevis juveniles, suggesting an orexigenic effect of corticosterone in frogs. We did not detect a negative effect of metyrapone on food intake in this study but, because appetite was extremely low in the control frogs, it was dif®cult to resolve signi®cant decreases in food intake.
Second, X. laevis exhibited an increase in corticosterone 6 h after satiation feeding, suggesting that the hypothalamic-pituitaryinter-renal (HPI) axis was stimulated by food intake. Similar increases in plasma corticosterone have been measured several hours after a meal in adult X. laevis (37) and ®shes (38±40). The timing of the postprandial glucose peak (24 h ) is also similar between X. laevis and ®shes. By contrast, rats and humans display a rapid, postprandial corticosterone`pulse' that occurs within minutes after a meal, followed by an equally rapid pulse in plasma glucose that returns to baseline concentrations within hours (35, 41) . The difference in timing of the postprandial corticosterone peak between amphibians/®sh and mammals may represent differences in metabolic rate (i.e. ectothermic versus endothermic), habitat (aquatic versus terrestrial), feeding modes (carnivores versus omnivores/herbivores), or inherent phylogenetic differences.
We propose that the difference in timing of the corticosterone peak may also re¯ect functional differences of glucocorticoids among vertebrate groups. In mammals, the rapid increase in plasma corticosterone is thought to stimulate a rapid increase in gluconeogenesis and increased glucose transport following a meal (41) . While corticosterone also stimulates gluconeogenesis in ®sh and amphibians (37, 40) , we showed that the elevation of plasma concentrations after a meal is associated with osmoregulatory changes in X. laevis. We measured a signi®cant increase in body water content 24 h after the meal, and observed that the intestines ®lled with¯uid within hours after the meal (although we did not quantify this). Corticosterone has been shown to regulate intestinal ion uptake, water absorption and enzyme production in diverse vertebrate species including amphibians (42), although aldosterone also can serve this function (and has been shown to increase in response to feeding) (37) . Most studies investigating the osmoregulatory role of corticosterone in amphibians and ®shes have focused on dehydration or exposure to hyper-or hypoosmotic aquatic environments (42) . However, it is possible that corticosterone may be playing an important osmoregulatory role in the digestive process that has yet to be described.
The increase in plasma corticosterone concentration after a meal in X. laevis has been previously interpreted as a circadian rhythm because concentrations peaked and returned to baseline concentrations within 24 h (37). Circadian rhythms in plasma corticosterone have been measured in other vertebrates, with increases in plasma corticosterone occurring just before the active phase when feeding typically takes place [®sh (38±40); birds (43± 44); mammals (45)]. We found that when food is restricted from frogs that had been maintained on a regular feeding schedule, modest increases in plasma corticosterone continue at the same time of day as the usual postprandial corticosterone peak. Although we did not measure plasma corticosterone at a suf®cient number of time points to fully describe a circadian rhythm, our data suggest that corticosterone secretion may have an endogenous rhythm that could be entrained by the timing of food intake.
Interestingly, neither plasma corticosterone concentration nor CRF mRNA content increased with periods of food deprivation up to 31 days in X. laevis. While plasma cortisol concentration also remains low with food deprivation in ®shes (46) , this result contrasts strikingly with the increase in plasma corticosterone observed after only hours of food deprivation in endothermic animals (3, 47, 48) . The increase in plasma corticosterone caused by food deprivation is thought to be a stress response that promotes increased appetite, foraging behaviour, and the mobilization of stored fuel in endotherms (48) . The maintenance of relatively low plasma corticosterone concentrations during food deprivation in X. laevis may re¯ect the low metabolic rate characteristic of ectothermic animals. Even after 31 days of food deprivation, X. laevis maintained a positive energy balance as re¯ected by constant plasma glucose concentrations and body mass (wet or dry). Thus, the activation of the HPI axis and a compensatory increase in plasma corticosterone would not be expected. Frogs may have just reached a state of negative energy balance at the end of the 31-day food deprivation period, as fat mass, plasma xBP25 levels and NPY mRNA content began to decline. This pattern suggests a strategy of energy conservation in situations of low food availability in amphibians, as opposed to a strategy of increased foraging and mobilization of stored fuels exhibited by endothermic vertebrates, such as birds and rodents, that have much higher energy requirements for survival (48) .
Finally, we documented the existence of at least two plasma IGFBPs in X. laevis. The molecular weight and plasma pro®les following food intake and deprivation of xBP25 are similar to those of IGFBP-1 observed in other vertebrates. In mammals, IGFBP-1 production is stimulated by long-term glucose deprivation, and the protein is thought to sequester free IGFs in blood plasma and prevent their action in peripheral tissues (i.e. IGFBP-1 exerts a glucose counterregulatory role by neutralizing the hypoglycemic potential of free IGF-I) (26±27). IGFBP-1 is also secreted in times of stress and periods of prolonged food deprivation in ®sh, presumably to restrict the growth-promoting/hypoglycemic actions of free IGF-I and thus to allow for the conservation of energy resources (27, 28) . In X. laevis juveniles, we showed a similar increase in plasma xBP25 with food restriction, but we do not yet know if this band corresponds to the X. laevis IGFBP-1.
In conclusion, our results show that, in X. laevis, exogenous NPY and corticosterone are orexigenic, and CRF is anorexigenic, as has been shown in other vertebrates. Furthermore, both NPY and CRF mRNA content varied with food intake in ways that were consistent with these effects on appetite. NPY mRNA content declined after a meal, when appetite was low, and increased when appetite was elevated. Conversely, CRH mRNA content remained low through prolonged periods of food deprivation when appetite was high. Plasma concentrations of corticosterone increased by 6 h after a meal, suggesting that food intake activates the HPI axis. This increase in plasma corticosterone concentration was associated with subsequent increases in plasma glucose and xBP 25 kDa (presumptive X. laevis IGFBP-1), and body water content. However, during periods of short-term or long-term food deprivation, neither plasma corticosterone concentration nor CRF content increased. The corticosterone pro®les associated with food intake and food deprivation are similar to those observed in ®shes, but are strikingly different from those of endotherms. These differences likely re¯ect physiological, ecological or phylogenetic differences among vertebrates. Future comparative studies of the neuroendocrine controls of food intake in a diversity of animals with varying life histories are needed for a more thorough understanding of the evolution of the regulation of energy balance in vertebrates.
